Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,030 | 0,042 | 17:50 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.06. | Glow Lifetech reports Q1 results | 5 | Seeking Alpha | ||
02.06. | Glow LifeTech Corp.: Glow Lifetech Reports 238% YoY Revenue Growth and Near-Breakeven EBITDA in Q1 2025, Marking Third Straight Quarter of 40%+ Sequential Revenue Growth | 226 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 2, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the first quarter... ► Artikel lesen | |
GLOW LIFETECH Aktie jetzt für 0€ handeln | |||||
01.05. | Glow Lifetech Corp. reports Q4 results | 4 | Seeking Alpha | ||
01.05. | Glow LifeTech Corp.: Glow Lifetech Reports 2024 Financials, Delivering Record Q4 Results with 46% Quarterly Revenue Growth and Strengthened Balance Sheet | 292 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 1, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the fourth quarter... ► Artikel lesen | |
25.03. | Glow Lifetech Corp: Glow Lifetech increases production capacity for Mod | 6 | Stockwatch | ||
25.03. | Glow LifeTech Corp.: Glow Lifetech Triples Capacity via Automated Production Line as MOD Becomes #2 Oils SKU in Ontario | 245 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 25, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is accelerating its expansion with the acquisition of a... ► Artikel lesen | |
12.02. | Glow Lifetech Corp: Glow launches in New Brunswick, plans expansion | 10 | Stockwatch | ||
12.02. | Glow LifeTech Corp.: Glow Lifetech Provides Commercial Update; Continued Growth Momentum with New Product Launch & National Expansion | 454 | Newsfile | Toronto, Ontario--(Newsfile Corp. - February 12, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a commercial update highlighting... ► Artikel lesen | |
27.01. | Glow LifeTech Corp.: Glow LifeTech Announces Appointment of David Côté to Board of Directors | 403 | Newsfile | Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the appointment of David Côté as a... ► Artikel lesen | |
13.01. | Glow LifeTech Corp.: Glow Lifetech Announces Expansion into New Brunswick Market with MOD Drops, Marking Atlantic Canada Debut | 383 | Newsfile | Toronto, Ontario--(Newsfile Corp. - January 13, 2025) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its expansion of its flagship MOD drops... ► Artikel lesen | |
27.12.24 | Glow Lifetech Corp: Glow Lifetech grants options to buy 3.65 million shares | 7 | Stockwatch | ||
27.12.24 | Glow LifeTech Corp.: Glow Lifetech Grants Stock Options | 850 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 27, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has granted 3,650,000... ► Artikel lesen | |
21.12.24 | Glow Lifetech Corp: Glow Lifetech issues 10M shares to Swiss PharmaCan | 6 | Stockwatch | ||
21.12.24 | Glow LifeTech Corp.: Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement | 919 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") announces that, further to its news release dated December... ► Artikel lesen | |
12.12.24 | Glow LifeTech Corp.: Glow Lifetech Announces Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement | 553 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 12, 2024) - Glow Lifetech Corp. (CSE: GLOW) ("Glow" or the "Company") announces it plans to issue 10,000,000 Shares at a deemed price of $0.20 per Share... ► Artikel lesen | |
02.12.24 | Glow LifeTech Corp.: Glow Lifetech Reports 49% Q/Q Revenue Growth, 73% Gross Margins, and Strengthened Balance Sheet in Q3 2024 | 605 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 2, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the third... ► Artikel lesen | |
29.11.24 | Glow LifeTech Corp.: Glow Lifetech Announces Closing of Non-Brokered Private Placement Offering of Units and Debt Settlement | 843 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 29, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has completed a non-brokered... ► Artikel lesen | |
05.11.24 | Glow LifeTech Corp.: Glow Lifetech Announces Non-Brokered Private Placement Offering of Units and Debt Settlement | 454 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 5, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it intends to complete a non-brokered... ► Artikel lesen | |
24.10.24 | Glow Lifetech gibt kommerzielles Update und erreicht dritten Platz unter den Marken für Öle, beschleunigt Vertrieb im Einzelhandel und stärkt Bilanz für nachhaltiges Wachstum | 520 | IR-WORLD | TORONTO, 22. Oktober 2024 - Glow Lifetech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO)
("Glow" oder das "Unternehmen") freut sich, ein kommerzielles Update zur Verfügung zu stellen... ► Artikel lesen | |
22.10.24 | Glow LifeTech Corp.: Glow Lifetech Provides Commercial Update; Achieves #3 Brand in Oils, Accelerates Retail Distribution, Strengthens Balance Sheet for Sustained Growth | 395 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a commercial update marking a significant... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 91,40 | -0,49 % | BioNTech: Rücksetzer nach Kurssprung - und nun? | Die Aktie von BioNTech hat nach dem Deal mit Bristo-Myers Squibb zu Wochenbeginn deutlich zulegen können. Nun kam es zu ersten Gewinnmitnahmen. DER AKTIONÄR wirft noch einmal einen genauen Blick auf... ► Artikel lesen | |
EVOTEC | 7,600 | +2,15 % | Bayer, Evotec, HelloFresh, Rheinmetall, SFC Energy, thyssenkrupp nucera - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
MEDIGENE | 0,120 | -0,42 % | Medigene AG: Segmentwechsel | Medigene AG,
Unterföhring, Landkreis München
Wertpapierart: Aktien
ISIN: DE000A40ESG2
bisheriges Segment: Regulierter Markt - Prime Standard
künftiges Segment: Regulierter Markt - General Standard
Änderung... ► Artikel lesen | |
BB BIOTECH | 32,250 | -2,42 % | Edison Investment Research Limited: Edison issues report on BB Biotech (BION) | Edison Investment Research Limited
Edison issues report on BB Biotech (BION) 10-Jun-2025 / 09:06 GMT/BST
The issuer is solely responsible for the content of this announcement.
... ► Artikel lesen | |
QIAGEN | 40,685 | -0,18 % | Biotech Report: Qiagen und Biontech wenig bewegt, US-Sektor fest | (shareribs.com) Frankfurt / New York 06.06.2025 - Biotech-Werte zeigten sich im deutschen Handel durchwachsen. Biontech und Qiagen korrigierten leicht. An der Wall Street legte der Sektor hingegen deutlich... ► Artikel lesen | |
CUREVAC | 4,860 | +36,29 % | ROUNDUP: Deutscher Pharmadeal - Biontech greift nach Curevac | MAINZ (dpa-AFX) - Das Mainzer Pharmaunternehmen Biontech will den Rivalen Curevac aus Tübingen übernehmen. Beabsichtigt sei, alle Aktien von Curevac zu erwerben, teilte Biontech am Donnerstag mit.... ► Artikel lesen | |
MODERNA | 23,550 | -4,79 % | Moderna-Aktie heute am Aktienmarkt kaum gefragt: Kurs fällt (22,7185 €) | An der US-amerikanischen Börse liegt das Wertpapier von Moderna derzeit im Minus. Das Papier kostete zuletzt 25,98 US-Dollar. Die Moderna-Aktie verzeichnet aktuell ein Minus von 4,70 Prozent. Sie hat... ► Artikel lesen | |
PAION | 0,025 | 0,00 % | Paion Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
VALNEVA | 2,682 | -2,54 % | Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ | IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV)Antibody levels remained high after six months in both dose groups,... ► Artikel lesen | |
AMGEN | 255,40 | +0,47 % | How Is Amgen's Stock Performance Compared to Other Pharmaceuticals Stocks? | ||
EPIGENOMICS | 0,880 | 0,00 % | EQS-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Epigenomics AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Epigenomics AG: Vorabbekanntmachung über die... ► Artikel lesen | |
NOVAVAX | 6,256 | +1,23 % | Novavax: CIC And Flu Vaccine Candidates Induce Immune Responses Similar To Licensed Comparators | WASHINGTON (dpa-AFX) - Novavax, Inc. (NVAX) reported results of the initial cohort of COVID-19-Influenza Combination and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza Phase... ► Artikel lesen | |
STRYKER | 327,20 | -1,39 % | Stryker receives FDA clearance for OptaBlate BVN Basivertebral Nerve Ablation System | Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich., May 19, 2025 /PRNewswire/... ► Artikel lesen | |
BIOFRONTERA | 2,490 | 0,00 % | PTA-Adhoc: Biofrontera AG: Biofrontera AG verhandelt über grundlegende Änderungen ihrer Zusammenarbeit mit der Biofrontera Inc. | DJ PTA-Adhoc: Biofrontera AG: BIOFRONTERA AG VERHANDELT ÜBER GRUNDLEGENDE ÄNDERUNGEN IHRER ZUSAMMENARBEIT MIT DER BIOFRONTERA INC
Veröffentlichung von Insiderinformationen gemäß Artikel 17... ► Artikel lesen | |
BIOGEN | 114,65 | -1,08 % | UCB & Biogen: Phase 3 Trial Of Dapirolizumab Pegol In Systemic Lupus Erythematosus Meets Main Goal | WESTON (dpa-AFX) - UCB (UCB) and Biogen Inc. (BIIB) presented additional detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L... ► Artikel lesen |